FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)